We are pleased to announce that Stéphanie Blanc, Senior Consultant at GenSearch, will be attending the GenoTher Summit 2025, 11 June in Évry, France.
Read more “GenoTher Summit 2025: Shaping the Future of Gene Therapy”
We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges 12-14 May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”
We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.
A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.
Heiko Bruhn, a key figure at GenSearch, will be attending the Swiss Biotech Day 2025 in Basel, one of Europe’s leading biotechnology conferences.
Last week, the GenSearch team had the opportunity to step into the kitchen at Refugee Food Paris and assist in preparing and serving meals for the community. It was a rewarding experience that brought us together in a different way—sharing time, effort, and care for those who need it most.
Read more “Refugee Food Paris”Pauline Rambaud, GenSearch has taken part in a roundtable by France Biotech entitled : Insights on the roles of CMOs, CTOs, and CSOs in innovative health companies.
Read more “Biotech Development Day – 18/11/2024”BECAUSE GREAT PROJECTS NEVER HAPPEN ALONE.
We hope you build strong alliances in 2025.
At the HealthTech Dinner last week, hosted by GenSearch and PwC Switzerland and, we gathered to explore one of today’s most impactful topics in healthcare: Transforming the future of obesity care.
The evening brought together brilliant minds in Pharma and Life Sciences, with insights shared by Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle from Nestlé Health Science.